Cargando…

EBV and human cancer

Detalles Bibliográficos
Autor principal:	Ko, Young-Hyeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314581/ https://www.ncbi.nlm.nih.gov/pubmed/25613727 http://dx.doi.org/10.1038/emm.2014.109

Ejemplares similares

EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
por: Hong, Mineui, et al.
Publicado: (2013)

Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients
por: Park, Sanghui, et al.
Publicado: (2008)

EBV and further emerging directions towards increased precision in gastric cancer treatment
por: Santos, Luana B. C., et al.
Publicado: (2022)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023)

Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab–CHOP
por: Hong, Jung Yong, et al.
Publicado: (2017)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

Resveratrol Prevents EBV Transformation and Inhibits the Outgrowth of EBV-Immortalized Human B Cells
por: Espinoza, J. Luis, et al.
Publicado: (2012)

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
por: Alberti, Andrea, et al.
Publicado: (2023)

EBV & lymphoma
por: Caballero, Dolores
Publicado: (2019)

EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
por: Png, Yi Tian, et al.
Publicado: (2021)

Severe Chronic Active EBV Infection in an Adult Patient: Case Report
por: Ha, Sang-Yoon, et al.
Publicado: (2004)

HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer
por: Lifang, Yang, et al.
Publicado: (2008)

EBV in situ hybridization study for non-Hodgkin's lymphomas.
por: Ko, Y. H., et al.
Publicado: (1994)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

Epstein–Barr virus (EBV) and polyomaviruses are detectable in oropharyngeal cancer and EBV may have prognostic impact
por: Carpén, Timo, et al.
Publicado: (2020)

Epstein–Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells
por: Chen, Yen-Ju, et al.
Publicado: (2011)

Adoptive Transfer of EBV Specific CD8(+) T Cell Clones Can Transiently Control EBV Infection in Humanized Mice
por: Antsiferova, Olga, et al.
Publicado: (2014)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

EBV Chronic Infections
por: Eligio, Pizzigallo, et al.
Publicado: (2010)

Antiviral Drugs for EBV
por: Pagano, Joseph S., et al.
Publicado: (2018)

Progress in EBV Vaccines
por: van Zyl, Dwain G., et al.
Publicado: (2019)

The Dynamic Roles of TGF-β Signalling in EBV-Associated Cancers
por: Velapasamy, Sharmila, et al.
Publicado: (2018)

Human immunity against EBV—lessons from the clinic
por: Tangye, Stuart G., et al.
Publicado: (2017)

Editorial: EBV Infection and Human Primary Immune Deficiencies
por: Cohen, Jeffrey I., et al.
Publicado: (2020)

From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity
por: Kanduc, Darja, et al.
Publicado: (2020)

Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues
por: WANG, AILIANG, et al.
Publicado: (2016)

EBV-Associated Cancer and Autoimmunity: Searching for Therapies
por: Capone, Giovanni, et al.
Publicado: (2015)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

LMP1(+)SLAMF1(high) cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells
por: Yoon, Heejei, et al.
Publicado: (2017)

The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma
por: Kim, Hyunsung, et al.
Publicado: (2022)

The Characteristics of Epstein‐Barr Virus (EBV)‐positive Diffuse Large B‐Cell Lymphoma: Comparison between EBV(+) and EBV(‐) Cases in Japanese Population
por: Kuze, Tetuo, et al.
Publicado: (2000)

Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

Age-related EBV positive clonal B-cell Lymphoid proliferation (EBV+-DLBCL)
por: Georgakopoulou, Eleni, et al.
Publicado: (2017)

Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV
por: Venturini, Cristina, et al.
Publicado: (2021)

Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2019)

Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas
por: Mundo, Lucia, et al.
Publicado: (2020)

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies
Publicado: (1992)

Generating CTLs against the subdominant EBV LMP antigens by transit expression of an A20 inhibitor with EBV LMP proteins in human DCs
por: Hong, Bangxing, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6pmm2hk0eoaicnu0011g3n14ql